NVCR

Novocure
$17.03
−$0.62 (−3.51%)Jul 27, 2026
7.3GoodMoatMint rating

MoatMint rates Novocure (NVCR) 7.3 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 7.6 out of 10.

Key metrics

The numbers that frame NVCR today
Market cap
$1.98B
P/E (TTM)
-13.3
EV / FCF
-83.1
Gross margin
76.1%
EV / Sales
3.0
ROIC
-19.5%
Div yield
0%
Debt / equity
0.7
52wk Low
$9.82
52wk High
$21.36

NVCR stock rating

How NVCR scores on quality, value, growth, momentum and financial health
7.3out of 10
Good overallStrong business, expensive priceTop 27% of ~5,000 US stocks
QualityGood7.6/10
GrowthGreat9.0/10
MomentumGood7.1/10
ValueFair3.2/10
Financial HealthFair3.1/10

Growth

Revenue and earnings trend for NVCR
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about NVCR
Is Novocure a good buy?
Yes. Novocure has excellent quality and strong momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Novocure is selling at a high price, which cuts against the buy case.
What is the market capitalization of NVCR?
Novocure's market capitalization is $1.98B.
What is the P/E ratio for NVCR stock?
Novocure's current P/E ratio is -13.3.
What is the 52-week high for NVCR stock?
The 52-week high for Novocure is $21.36. The current close of $17.03 is 20.3% below that high.
What is the 52-week low for NVCR stock?
The 52-week low for Novocure is $9.82. The current close of $17.03 is 73.4% above that low.
Does NVCR stock pay dividends?
Novocure does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NVCR?
Novocure's Debt / Equity ratio is 0.69.